BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,223,103 | -28.9% | 138,397 | -14.1% | 0.03% | -24.4% |
| Q2 2023 | $7,341,948 | +16.0% | 161,149 | +3.2% | 0.04% | +7.1% |
| Q1 2023 | $6,330,848 | -20.1% | 156,086 | +0.4% | 0.04% | -23.6% |
| Q4 2022 | $7,923,337 | +0.6% | 155,451 | +6.3% | 0.06% | -3.5% |
| Q3 2022 | $7,874,000 | -17.9% | 146,192 | -2.1% | 0.06% | -12.3% |
| Q2 2022 | $9,595,000 | -28.3% | 149,386 | -13.4% | 0.06% | -11.0% |
| Q1 2022 | $13,380,000 | -11.9% | 172,562 | -2.4% | 0.07% | -3.9% |
| Q4 2021 | $15,179,000 | +6.0% | 176,824 | -0.7% | 0.08% | 0.0% |
| Q3 2021 | $14,317,000 | -2.0% | 178,003 | -1.9% | 0.08% | +55.1% |
| Q2 2021 | $14,603,000 | -6.6% | 181,407 | -2.2% | 0.05% | -10.9% |
| Q1 2021 | $15,643,000 | +1.8% | 185,475 | -3.2% | 0.06% | -3.5% |
| Q4 2020 | $15,369,000 | -3.2% | 191,535 | -2.9% | 0.06% | -25.0% |
| Q3 2020 | $15,869,000 | -10.0% | 197,330 | -3.6% | 0.08% | -10.6% |
| Q2 2020 | $17,634,000 | +9.2% | 204,804 | +3.0% | 0.08% | -3.4% |
| Q1 2020 | $16,142,000 | -2.7% | 198,820 | +0.3% | 0.09% | +37.5% |
| Q4 2019 | $16,582,000 | -3.5% | 198,303 | +0.9% | 0.06% | -7.2% |
| Q3 2019 | $17,184,000 | +12.9% | 196,455 | +5.7% | 0.07% | +16.9% |
| Q2 2019 | $15,216,000 | -9.4% | 185,789 | -10.0% | 0.06% | -7.8% |
| Q1 2019 | $16,788,000 | +19.4% | 206,463 | -3.4% | 0.06% | +10.3% |
| Q4 2018 | $14,063,000 | -18.3% | 213,652 | -4.4% | 0.06% | +1.8% |
| Q3 2018 | $17,222,000 | +10.4% | 223,402 | +5.8% | 0.06% | +5.6% |
| Q2 2018 | $15,597,000 | +12.5% | 211,233 | -0.9% | 0.05% | +12.5% |
| Q1 2018 | $13,864,000 | -0.1% | 213,155 | -0.7% | 0.05% | +4.3% |
| Q4 2017 | $13,875,000 | +39.3% | 214,649 | +35.2% | 0.05% | +31.4% |
| Q3 2017 | $9,959,000 | -4.1% | 158,714 | -7.5% | 0.04% | -5.4% |
| Q2 2017 | $10,390,000 | +17.7% | 171,614 | +0.8% | 0.04% | +15.6% |
| Q1 2017 | $8,830,000 | +15.9% | 170,262 | -0.9% | 0.03% | +10.3% |
| Q4 2016 | $7,619,000 | -99.9% | 171,841 | -0.8% | 0.03% | -12.1% |
| Q3 2016 | $8,246,129,000 | -5.2% | 173,238 | -10.0% | 0.03% | -10.8% |
| Q2 2016 | $8,702,499,000 | -13.8% | 192,448 | -21.7% | 0.04% | -5.1% |
| Q1 2016 | $10,100,000,000 | -6.8% | 245,851 | -13.4% | 0.04% | -13.3% |
| Q4 2015 | $10,832,000,000 | +60542.7% | 283,945 | -47.8% | 0.04% | -42.3% |
| Q3 2015 | $17,862,000 | -99.9% | 543,759 | +32.8% | 0.08% | -32.2% |
| Q2 2015 | $28,636,483,000 | +5.2% | 409,502 | +3.0% | 0.12% | +2.7% |
| Q1 2015 | $27,232,829,000 | +8.2% | 397,559 | +15.8% | 0.11% | +2.8% |
| Q4 2014 | $25,158,736,000 | +3.5% | 343,277 | +1.4% | 0.11% | +1.9% |
| Q3 2014 | $24,298,361,000 | +4.9% | 338,559 | +5.7% | 0.11% | +4.9% |
| Q2 2014 | $23,165,101,000 | -0.4% | 320,403 | +1.4% | 0.10% | -6.4% |
| Q1 2014 | $23,256,945,000 | +14.3% | 316,077 | +8.1% | 0.11% | +11.2% |
| Q4 2013 | $20,344,001,000 | +62.5% | 292,509 | +53.5% | 0.10% | +44.1% |
| Q3 2013 | $12,520,382,000 | -2.9% | 190,598 | +2.4% | 0.07% | -11.7% |
| Q2 2013 | $12,889,277,000 | – | 186,073 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |